articleTop 1% cited
Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR
Allergy · 2004 · Vol. 59(7) · pp. 709–717
A M Vignola✉(University of Palermo)Marc Humbert(Hôpital Antoine-Béclère)Jean Bousquet(Hôpital Arnaud de Villeneuve)LP Boulet(Institut Universitaire de Cardiologie et de Pneumologie de Québec)S. Hedgecock(Novartis (United Kingdom))Martin Blogg(Novartis (United Kingdom))Helen Fox(Novartis (United Kingdom))K. Surrey(Novartis (United Kingdom))
Abstract
Omalizumab is well tolerated and effective in preventing asthma exacerbations and improving quality of life in patients with concomitant asthma and persistent allergic rhinitis.
Asthma and respiratory diseasesAllergic Rhinitis and SensitizationRespiratory and Cough-Related ResearchOmalizumabMedicineTolerabilityConcomitantAsthmaPlaceboImmunoglobulin EAdverse effectBudesonideInternal medicine
MeSH terms
OmalizumabAdolescentAdultAgedAntibodies, Anti-IdiotypicAntibodies, MonoclonalAsthmaChildDouble-Blind MethodFemaleHumansImmunoglobulin EMaleMiddle AgedQuality of Life
Funding
- Novartis
- Novartis Pharma
Citations
404
FWCI
14.38
field-weighted impact
References
39
Percentile
99%
vs. same field & year
Citations per year
Cited by
Paediatric rhinitis: position paper of the <scp>E</scp>uropean <scp>A</scp>cademy of Allergy and <scp>C</scp>linical <scp>I</scp>mmunology
Allergy · 2013 · 393 citations
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
European Respiratory Journal · 2013 · 3,864 citations
The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
Allergy · 2004 · 399 citations
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Allergy · 2004 · 1,110 citations
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Journal of Allergy and Clinical Immunology · 2010 · 1,827 citations
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Allergy · 2008 · 4,669 citations
References
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
European Respiratory Journal · 2001 · 826 citations
Determining a minimal important change in a disease-specific quality of life questionnaire
Journal of Clinical Epidemiology · 1994 · 1,824 citations
Allergic Rhinitis and Its Impact on Asthma
Journal of Allergy and Clinical Immunology · 2001 · 3,543 citations
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
Journal of Allergy and Clinical Immunology · 2001 · 1,287 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.